Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: Results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles

Neil Swanson, William Abramovits, Brian Berman, James Kulp, Darrell S. Rigel, Sharon Levy

Research output: Contribution to journalArticlepeer-review

119 Scopus citations

Fingerprint

Dive into the research topics of 'Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: Results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles'. Together they form a unique fingerprint.

Medicine & Life Sciences